DK1608982T3 - Diagnose af autisme - Google Patents

Diagnose af autisme

Info

Publication number
DK1608982T3
DK1608982T3 DK04716392T DK04716392T DK1608982T3 DK 1608982 T3 DK1608982 T3 DK 1608982T3 DK 04716392 T DK04716392 T DK 04716392T DK 04716392 T DK04716392 T DK 04716392T DK 1608982 T3 DK1608982 T3 DK 1608982T3
Authority
DK
Denmark
Prior art keywords
seq
autism
diagnosis
peptides
skithrihwesasll
Prior art date
Application number
DK04716392T
Other languages
Danish (da)
English (en)
Inventor
Anders Grubb
Original Assignee
Momeni Naghi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momeni Naghi filed Critical Momeni Naghi
Application granted granted Critical
Publication of DK1608982T3 publication Critical patent/DK1608982T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK04716392T 2003-03-04 2004-03-02 Diagnose af autisme DK1608982T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0300586A SE0300586L (sv) 2003-03-04 2003-03-04 Diagnos av autism
PCT/SE2004/000193 WO2004079371A1 (en) 2003-03-04 2004-03-02 Diagnosis of autism

Publications (1)

Publication Number Publication Date
DK1608982T3 true DK1608982T3 (da) 2007-11-26

Family

ID=20290572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04716392T DK1608982T3 (da) 2003-03-04 2004-03-02 Diagnose af autisme

Country Status (19)

Country Link
US (1) US8268576B2 (xx)
EP (1) EP1608982B9 (xx)
JP (1) JP4452715B2 (xx)
KR (1) KR101096487B1 (xx)
CN (1) CN1795386B (xx)
AT (1) ATE371192T1 (xx)
AU (1) AU2004217571B2 (xx)
BR (1) BRPI0408067A (xx)
CA (1) CA2518066C (xx)
DE (1) DE602004008439T2 (xx)
DK (1) DK1608982T3 (xx)
ES (1) ES2293234T3 (xx)
NZ (1) NZ542149A (xx)
PL (1) PL1608982T3 (xx)
PT (1) PT1608982E (xx)
RU (1) RU2340900C2 (xx)
SE (1) SE0300586L (xx)
WO (1) WO2004079371A1 (xx)
ZA (1) ZA200507082B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4677556B2 (ja) * 2005-04-22 2011-04-27 国立大学法人 千葉大学 自閉症の診断薬
SG182971A1 (en) * 2007-07-26 2012-08-30 Phenomenome Discoveries Inc Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
CA2821908C (en) * 2010-12-16 2018-09-18 Autism Biotech Limited Novel biomarker and uses thereof in diagnosis, treatment of autism
WO2014018468A1 (en) 2012-07-22 2014-01-30 Indiana University Research And Technology Corporation Modulation sapp, sapp alpha and bdnf levels in individuals diagnosed with fxs and asd
PL3058371T3 (pl) 2013-10-14 2021-11-08 Indiana University Research And Technology Corporation Zastosowanie akamprozatu do modulowania aktywacji erk 1-2 w modelach zwierzęcych dla fxs i asd oraz u osób z rozpoznaniem fxs i asd
CN105652016A (zh) * 2016-01-28 2016-06-08 深圳大学 一种孤独症检测标志物及其检测方法
US11131681B2 (en) * 2017-03-10 2021-09-28 Dr. Raymond Laboratories, Inc. Method for diagnosing psychiatric disorders
WO2018164536A1 (ko) 2017-03-10 2018-09-13 스핑고브레인 주식회사 정신장애의 진단 방법
RU2643760C1 (ru) * 2017-08-07 2018-02-05 Федеральное государственное бюджетное научное учреждение "Научный центр психического здоровья" Способ определения необходимости использования психофармакотерапии у пациентов с расстройствами аутистического спектра на момент их обследования
KR20190106442A (ko) 2018-03-09 2019-09-18 스핑고브레인 주식회사 태지, 양수 또는 제대혈을 이용한 정신장애의 진단 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273683A1 (en) * 1998-06-15 1999-12-15 Ortho-Clinical Diagnostics, Inc. Diagnostic markers for human disorders
IT1303675B1 (it) * 1998-08-04 2001-02-23 Radim S P A Metodo di determinazione di peptidi utilizzati come marker per ladiagnosi dell'autismo
CA2387801A1 (en) 1999-11-04 2001-05-10 Human Genome Sciences, Inc. Uteroglobin-like polynucleotides, polypeptides, and antibodies
US6998243B2 (en) 2001-04-30 2006-02-14 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons

Also Published As

Publication number Publication date
EP1608982B9 (en) 2008-07-23
EP1608982B1 (en) 2007-08-22
PL1608982T3 (pl) 2008-01-31
PT1608982E (pt) 2007-11-09
RU2340900C2 (ru) 2008-12-10
AU2004217571B2 (en) 2009-03-12
KR20060006774A (ko) 2006-01-19
ES2293234T3 (es) 2008-03-16
CA2518066C (en) 2011-05-10
US8268576B2 (en) 2012-09-18
ATE371192T1 (de) 2007-09-15
CN1795386A (zh) 2006-06-28
US20120149038A1 (en) 2012-06-14
ZA200507082B (en) 2007-02-28
CN1795386B (zh) 2010-08-25
DE602004008439T2 (de) 2008-05-21
CA2518066A1 (en) 2004-09-16
KR101096487B1 (ko) 2011-12-20
WO2004079371A1 (en) 2004-09-16
JP2006519391A (ja) 2006-08-24
JP4452715B2 (ja) 2010-04-21
EP1608982A1 (en) 2005-12-28
SE0300586L (sv) 2004-09-05
RU2005130641A (ru) 2006-02-10
AU2004217571A1 (en) 2004-09-16
SE0300586D0 (sv) 2003-03-04
NZ542149A (en) 2008-03-28
DE602004008439D1 (de) 2007-10-04
BRPI0408067A (pt) 2006-02-14

Similar Documents

Publication Publication Date Title
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
HK1089232A1 (en) Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
MA29282B1 (fr) Procede de diagnostic d'une steatose hepatique au moyen de marqueurs biochimiques
DK1608982T3 (da) Diagnose af autisme
ATE283289T1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE602004011105D1 (de) Verfahren, peptide und biosensoren mit eignung zum nachweis eines breiten spektrums von bakterien
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
DE602005012530D1 (de) Immunogene glykopeptide zur diagnose von infektionen pathogener mikroorganismen
ATE547523T1 (de) Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden
DE60219645D1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
CA2366523A1 (en) Method for analyzing the amount of intraabdominal adipose tissue
BR0317404A (pt) Variantes do fator xiia
ATE511646T1 (de) Diagnose mykobakterieller infektionen mittels bestimmung von ifn-gamma
DE60334408D1 (de) Nsäuren
EP2290093A3 (fr) Procédé de détection de la PRP utilisant une molécule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
GB0223655D0 (en) Method of diagnosis
DE602004022995D1 (de) Verfahren zur diagnose der immunität wiederkehrendren zur behandlung und überwachung
DE60225845D1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie
ATE478147T1 (de) Aus einem neuroblastom isolierte nukleinsäuren
PT1527197E (pt) Associação do polimorfismo v286a da edg5 com diabetes mellitus do tipo ii e trombose venosa/embolismo pulmonar e a sua utilização
CA2588614A1 (en) Method for analyzing the amount of intraabdominal adipose tissue
WO2002065129A3 (en) Epitopic sequences for diagnosing infection by chlamydia trachomatis
WO2005124362A3 (de) Verfahren und testkit zur diagnose einer ischämischen herzschädigung, insbesondere der latenten chronischen formen, durch serologischen nachweis der myosin lechtkette-1